Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Contact information


rachel.dunn@oncology.ox.ac.uk

Rachel Austin

Trial Manager

I joined the Oncology Clinical Trials Office (OCTO) in December 2018. After several years working as a Clinical Trials Administrator, I have since progressed to a Trial Manager position. Previously I worked within the NHS at the Warneford Hospital, and then the John Radcliffe Hospital.

Trials I am currently working on:

  • SCOOT - This study aims to use blood biomarkers to support quicker and more accurate diagnosis of lung cancers.

Publications: 

  • Randomised Phase II Trial of Olaparib, chemotherapy, or Olaparib and Cediranib in patients with platinum-resistant ovarian cancer (OCTOVA): a study protocol (https://www.oncology.ox.ac.uk/publications/1149973)